These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6205212)

  • 21. Is programmed stimulation of value in predicting the long-term success of antiarrhythmic therapy for ventricular tachycardias?
    Kim SG; Seiden SW; Felder SD; Waspe LE; Fisher JD
    N Engl J Med; 1986 Aug; 315(6):356-62. PubMed ID: 2426592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [High spontaneous variability of ventricular arrhythmias limits the evidence gained by long-term ECG studies].
    Bertel O; Braun S; Schmid P; Burkart F
    Schweiz Med Wochenschr; 1979 Nov; 109(43):1670-2. PubMed ID: 93782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ventricular premature beats in a population sample. Frequency and associations with coronary risk characteristics.
    Crow RS; Prineas RJ; Dias V; Taylor HL; Jacobs D; Blackburn H
    Circulation; 1975 Dec; 52(6 Suppl):III211-5. PubMed ID: 52417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Holter analysis of ventricular arrhythmias and its treatment with propafenone].
    Peralta Heredia R
    Arch Inst Cardiol Mex; 1986; 56(3):225-30. PubMed ID: 2428317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ventricular premature beats and mortality of men with coronary heart disease.
    Ruberman W; Weinblatt E; Frank CW; Goldberg JD; Shapiro S; Feldman CL
    Circulation; 1975 Dec; 52(6 Suppl):III199-203. PubMed ID: 52415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Spontaneous variability of ventricular extrasystole in chronic Chagas cardiopathy].
    Grupi CJ; Sosa EA; De Carvalho JF; Antonelli RH; Bellotti G; Pileggi F
    Arq Bras Cardiol; 1991 Jun; 56(6):445-50. PubMed ID: 1726676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of antiarrhythmic drug efficacy using holter electrocardiographic technique.
    Tanabe T; Yoshikawa H; Tagawa R; Furuya H; Ide M; Goto Y
    Jpn Circ J; 1985 Mar; 49(3):337-44. PubMed ID: 2580107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of an acute drug test in the differentiated therapy of ventricular extrasystole].
    Tatarchenko IP; Perevarin AV; Oleĭnikov VE
    Kardiologiia; 1990 Sep; 30(9):84-5. PubMed ID: 1703257
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG].
    Ferrara E; Vitali A; Cucchi GF
    Minerva Cardioangiol; 1985 Sep; 33(9):553-6. PubMed ID: 2418385
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effectiveness of ethacizin in ventricular arrhythmias refractory to prior anti-arrhythmia drug therapy].
    Shugushev KhKh
    Kardiologiia; 1986 Jun; 26(6):43-7. PubMed ID: 2429007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of Holter monitoring and electrophysiological studies in the evaluation of ventricular anti-arrhythmia agents].
    Frank R; Raguin D; Tonet J; Fontaine G
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():21-5. PubMed ID: 1726995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relations between ventricular extrasystole, time of day and heart rate].
    Andresen D; von Leitner ER; Wegscheider K; Schröder R
    Z Kardiol; 1982 Oct; 71(10):669-73. PubMed ID: 6186096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of patients at risk for sudden heart death by long-term ECG. The role of life-threatening ventricular arrhythmias].
    Hombach V; Höpp HW; Osterspey A; Winter U; Deutsch H; Hilger HH
    Herz; 1984 Feb; 9(1):6-25. PubMed ID: 6200415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Variability and stability of ventricular extrasystole in patients with a history of myocardial infarction].
    Sumarokov AB; Mazur NA
    Kardiologiia; 1986 Dec; 26(12):38-44. PubMed ID: 2435947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-arrhythmic effectiveness of neogilurhythmal in extrasystolic arrhythmia].
    Kobuliia BG; Maĭsuradze MZ; Mindadze KA; Imnadze GN; Saatashvili GA
    Kardiologiia; 1992 Jun; 32(6):38-9. PubMed ID: 1383594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of ventricular extrasystole].
    Seipel L
    Dtsch Med Wochenschr; 1989 Oct; 114(41):1571-5. PubMed ID: 2478353
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of data from exercise tests and continuous electrocardiographic recording in patients with ventricular extrasystole. Apropos of 131 cases].
    Laurent M; Miane B; Almange C; Leborgne P
    Arch Mal Coeur Vaiss; 1982 Jun; 75(6):653-62. PubMed ID: 6180694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness and characteristics of the action of etmozin in treating extrasystole in middle-aged and elderly patients].
    Korkushko OV; Butenko AG; Kaukenas IK
    Ter Arkh; 1986; 58(6):65-70. PubMed ID: 2429380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation with dynamic ECG of the spontaneous and circadian variations of the frequency of complicated ventricular extrasystole].
    Naccarella F; Del Corso P; Pavesi PC; Palmieri M; Lombardi G; Bracchetti D
    Boll Soc Ital Cardiol; 1980; 25(5):525-31. PubMed ID: 6169357
    [No Abstract]   [Full Text] [Related]  

  • 40. [Non-invasive method of evaluating anti-arrhythmia drug efficacy].
    Doniwa K; Maeda G; Okajima M
    Nihon Rinsho; 1985 Nov; 43(11):2417-21. PubMed ID: 2418226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.